Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221–1231 (2002).
Google Scholar
Vadarlis, A. et al. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 36, 311–319 (2021).
Google Scholar
Afzali, N. et al. Effect of Beta vulgaris extract on liver enzymes in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Hepat. Mon. 20, e102125 (2020).
Google Scholar
Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11–20 (2018).
Google Scholar
Estes, C. et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123–133 (2018).
Google Scholar
Li, H. et al. Association between consumption of edible seaweeds and newly diagnosed non-alcohol fatty liver disease: The TCLSIH Cohort Study. Liver Int. 41, 311–320 (2021).
Google Scholar
Younossi, Z. M. & Henry, L. The impact of obesity and type 2 diabetes on chronic liver disease. Am. J. Gastroenterol. 114, 1714–1715 (2019).
Google Scholar
Targher, G. et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J. Hepatol. 65, 589–600 (2016).
Google Scholar
Le, M. H. et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One 12, e0173499 (2017).
Google Scholar
Rinella, M. E. et al. Controversies in the diagnosis and management of NAFLD and NASH. Gastroenterol. Hepatol. (N Y) 10, 219–227 (2014).
Google Scholar
Pietu, F. et al. Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: Long-term results. Clin. Res. Hepatol. Gastroenterol. 36, 146–155 (2012).
Google Scholar
Sun, Y. et al. Association of dietary fiber intake with hyperuricemia in U.S. adults. Food Funct. 10, 4932–4940 (2019).
Google Scholar
Buil-Cosiales, P. et al. Consumption of fruit or fiber-fruit decreases the risk of cardiovascular disease in a Mediterranean young cohort. Nutrients 9, 295 (2017).
Google Scholar
Yao, B. et al. Dietary fiber intake and risk of type 2 diabetes: A dose-response analysis of prospective studies. Eur. J. Epidemiol. 29, 79–88 (2014).
Google Scholar
Sun, B. et al. Exploration of the association between dietary fiber intake and hypertension among U.S. adults using 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: NHANES 2007–2014. Nutrients 10, 1091 (2018).
Google Scholar
Kranz, S. et al. Whole grains contribute only a small proportion of dietary fiber to the U.S. diet. Nutrients 9, 153 (2017).
Google Scholar
Mollard, R. C. et al. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am. J. Clin. Nutr. 99, 804–812 (2014).
Google Scholar
Ouyang, X. et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48, 993–999 (2008).
Google Scholar
Shim, P., Choi, D. & Park, Y. Association of blood fatty acid composition and dietary pattern with the risk of non-alcoholic fatty liver disease in patients who underwent cholecystectomy. Ann. Nutr. Metab. 70, 303–311 (2017).
Google Scholar
Dorosti, M. et al. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: A randomised controlled clinical trial. Br. J. Nutr. 123, 328–336 (2020).
Google Scholar
Koutnikova, H. et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: A systematic review and meta-analysis of randomised controlled trials. BMJ Open 9, e017995 (2019).
Google Scholar
Maleki, Z. et al. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complement. Ther. Med. 44, 44–50 (2019).
Google Scholar
Al-Busafi, S. A. et al. Antioxidant therapy in nonalcoholic steatohepatitis. Hepat. Res. Treat. 2012, 947575 (2012).
Google Scholar
Pickett-Blakely, O., Young, K. & Carr, R. M. Micronutrients in nonalcoholic fatty liver disease pathogenesis. Cell Mol. Gastroenterol. Hepatol. 6, 451–462 (2018).
Google Scholar
USDA, ARS. What We Eat in America, NHANES 2009–2010. http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/0910/Table_1_NIN_GEN_09.pdf. Accessed 23 Feb 2011 (2011).
Reboul, E. Absorption of vitamin A and carotenoids by the enterocyte: Focus on transport proteins. Nutrients 5, 3563–3581 (2013).
Google Scholar
Hollander, D. & Muralidhara, K. S. Vitamin A1 intestinal absorption in vivo: Influence of luminal factors on transport. Am. J. Physiol. 232, E471-477 (1977).
Google Scholar
Hollander, D. & Ruble, P. E. Jr. beta-carotene intestinal absorption: Bile, fatty acid, pH, and flow rate effects on transport. Am. J. Physiol. 235, E686-691 (1978).
Google Scholar
Hollander, D. Intestinal absorption of vitamins A, E, D, and K. J. Lab. Clin. Med. 97, 449–462 (1981).
Google Scholar
Bawa, F. N. C. & Zhang, Y. Retinoic acid signaling in fatty liver disease. Liver Res. 7, 189–195 (2023).
Google Scholar
Yilmaz, B. et al. Carotenoids and non-alcoholic fatty liver disease. Hepatobiliary Surg. Nutr. 4, 161–171 (2015).
Google Scholar
Lotfi, A. et al. The relationship between dietary antioxidant intake and physical activity rate with nonalcoholic fatty liver disease (NAFLD): A case–control study. Clin. Nutr. ESPEN 34, 45–49 (2019).
Google Scholar
Vahid, F., Rahmani, D. & Hekmatdoost, A. The association between dietary antioxidant index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case–control study. Clin. Nutr. ESPEN 41, 360–364 (2021).
Google Scholar
Ma, C. et al. Negative association between antioxidant vitamin intake and non-alcoholic fatty liver disease in Chinese non-diabetic adults: Mediation models involving superoxide dismutase. Free Radic. Res. 54, 670–677 (2020).
Google Scholar
Lim, H. S. et al. Association between inflammatory biomarkers and nutritional status in fatty liver. Clin. Nutr. Res. 9, 182–194 (2020).
Google Scholar
Federico, A. et al. Qualitative and quantitative evaluation of dietary intake in patients with non-alcoholic steatohepatitis. Nutrients 9, 1074 (2017).
Google Scholar
NCHS. National Health and Nutrition Examination Survey (NHANES). http://www.cdcgov/nchs/nhaneshtm. Accessed 26 Aug 2022 (2022).
Zipf, G. et al. National health and nutrition examination survey: Plan and operations, 1999–2010. Vital Health Stat. 1, 1–37 (2013).
Choi, W. J. et al. Independent association of serum retinol and beta-carotene levels with hyperuricemia: A national population study. Arthritis Care Res. (Hoboken) 64, 389–396 (2012).
Google Scholar
Zhai, T. et al. Prevalence and trends in low bone density, osteopenia and osteoporosis in U.S. adults with non-alcoholic fatty liver disease, 2005–2014. Front. Endocrinol. (Lausanne) 12, 825448 (2021).
Google Scholar
Ruhl, C. E. & Everhart, J. E. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol. Ther. 41, 65–76 (2015).
Google Scholar
Kim, D. et al. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016. Hepatol. Int. 13, 205–213 (2019).
Google Scholar
Kim, D. et al. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol. Ther. 50, 590–598 (2019).
Google Scholar
Meffert, P. J. et al. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis. Am. J. Gastroenterol. 109, 1404–1414 (2014).
Google Scholar
Zhang, P. et al. Association between retinol intake and hyperuricaemia in adults. Public Health Nutr. 24, 2205–2214 (2021).
Google Scholar
U.S. Department of Agriculture, Agricultural Research Service. USDA Food and Nutrient Database for Dietary Studies 2011–2012. Food Surveys Research Group Home Page. http://www.ars.usda.gov/ba/bhnrc/fsrg (2014).
Menke, A. et al. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 314, 1021–1029 (2015).
Google Scholar
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71, e13–e115 (2018).
Google Scholar
Chen, T. C. et al. National Health and Nutrition Examination Survey: Estimation procedures, 2011–2014. Vital Health Stat. 2, 1–26 (2018).
Mecocci, P. et al. Plasma antioxidants and longevity: A study on healthy centenarians. Free Radic. Biol. Med. 28, 1243–1248 (2000).
Google Scholar
Edwards, A. J. et al. A novel extrinsic reference method for assessing the vitamin A value of plant foods. Am. J. Clin. Nutr. 74, 348–355 (2001).
Google Scholar
Edwards, A. J. et al. Alpha- and beta-carotene from a commercial puree are more bioavailable to humans than from boiled-mashed carrots, as determined using an extrinsic stable isotope reference method. J. Nutr. 132, 159–167 (2002).
Google Scholar
Yeum, K. J. & Russell, R. M. Carotenoid bioavailability and bioconversion. Annu. Rev. Nutr. 22, 483–504 (2002).
Google Scholar
Hickenbottom, S. J. et al. Variability in conversion of beta-carotene to vitamin A in men as measured by using a double-tracer study design. Am. J. Clin. Nutr. 75, 900–907 (2002).
Google Scholar
Ni, Y. et al. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. Endocrinology 156, 987–999 (2015).
Google Scholar
Elvira-Torales, L. I., García-Alonso, J. & Periago-Castón, M. J. Nutritional importance of carotenoids and their effect on liver health: A review. Antioxidants (Basel) 8, 229 (2019).
Google Scholar
Christensen, K., Lawler, T. & Mares, J. Dietary carotenoids and non-alcoholic fatty liver disease among US adults, NHANES 2003(-)2014. Nutrients 11, 1101 (2019).
Google Scholar
Yoneda, M. et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J. Gastroenterol. 42, 573–582 (2007).
Google Scholar
Abe, R. A. M. et al. The role of vitamins in non-alcoholic fatty liver disease: A systematic review. Cureus 13, e16855 (2021).
Google Scholar
Shih, P. H. et al. Fucoidan and fucoxanthin attenuate hepatic steatosis and inflammation of NAFLD through modulation of leptin/adiponectin axis. Mar. Drugs 19, 148 (2021).
Google Scholar
Iwaki, M. et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655–1663 (2003).
Google Scholar
Cimini, F. A. et al. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World J. Gastroenterol. 23, 3407–3417 (2017).
Google Scholar
Mells, J. E. et al. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. J. Nutr. Biochem. 26, 285–292 (2015).
Google Scholar
Wei, J. et al. Association between dietary vitamin C intake and non-alcoholic fatty liver disease: A cross-sectional study among middle-aged and older adults. PLoS One 11, e0147985 (2016).
Google Scholar
Abdel-Maboud, M. et al. The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression. Ther. Adv. Gastroenterol. 13, 1756284820974917 (2020).
Google Scholar
Wang, K. et al. New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. Biomed. Pharmacother. 137, 111326 (2021).
Google Scholar
